vTv Therapeutics (VTVT) News Today $13.69 -0.73 (-5.06%) (As of 10/11/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period vTv Therapeutics (NASDAQ:VTVT) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comvTv Therapeutics (NASDAQ:VTVT) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comvTv Therapeutics (NASDAQ:VTVT) Stock Passes Below Fifty Day Moving Average of $15.13October 3, 2024 | americanbankingnews.comWe're Keeping An Eye On vTv Therapeutics' (NASDAQ:VTVT) Cash Burn RateAugust 16, 2024 | finance.yahoo.comVTVT Stock Earnings: vTv Therapeutics Reported Results for Q2 2024August 9, 2024 | investorplace.comvTv Therapeutics Inc.: vTv Therapeutics Announces 2024 Second Quarter Financial Results and Provides Corporate UpdateAugust 9, 2024 | finanznachrichten.devTv Therapeutics Announces 2024 Second Quarter Financial Results and Provides Corporate UpdateAugust 8, 2024 | globenewswire.comvTv Therapeutics' stock plunges after FDA pauses High Point company's diabetes drug developmentAugust 1, 2024 | bizjournals.comWhy Is vTv Therapeutics (VTVT) Stock Down 46% Today?July 29, 2024 | investorplace.comvTv Therapeutics Inc.: vTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical HoldJuly 28, 2024 | finanznachrichten.deStocks to Watch: vTv Therapeutics, BJ's Restaurants, Warner Bros. DiscoveryJuly 26, 2024 | marketwatch.comVTv Therapeutics's Cadisegliatin Program For Type 1 Diabetes Placed On Clinical Hold, Stock TanksJuly 26, 2024 | markets.businessinsider.comVTv Therapeutics' Cadisegliatin Clinical Program Put On Hold By FDAJuly 26, 2024 | marketwatch.comvTv Therapeutics Shares Tumble After FDA Pauses Diabetes-Treatment Study >VTVTJuly 26, 2024 | marketwatch.comvTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical HoldJuly 26, 2024 | globenewswire.com5VT0.MU,0P0001EVLU,0 (5VT0.MU)July 23, 2024 | sg.finance.yahoo.comVTV THERAPEUT. A NEW O.N. (5VT0.BE)July 23, 2024 | sg.finance.yahoo.comvTv Therapeutics (NASDAQ:VTVT) Share Price Crosses Below 50 Day Moving Average of $22.15vTv Therapeutics (NASDAQ:VTVT) Shares Pass Below Fifty Day Moving Average of $22.15July 11, 2024 | marketbeat.comvTv Therapeutics Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 DiabetesJune 24, 2024 | globenewswire.comCANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETINGMay 28, 2024 | prnewswire.comShareholders in vTv Therapeutics (NASDAQ:VTVT) are in the red if they invested three years agoMay 27, 2024 | finance.yahoo.comvTv Therapeutics (NASDAQ:VTVT) Stock Passes Above 50-Day Moving Average of $24.72vTv Therapeutics (NASDAQ:VTVT) Stock Crosses Above 50 Day Moving Average of $24.72May 22, 2024 | marketbeat.comvTv Therapeutics Inc.: vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate UpdateMay 11, 2024 | finanznachrichten.deVTVT Stock Earnings: vTv Therapeutics Reported Results for Q1 2024May 10, 2024 | investorplace.comvTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate UpdateMay 9, 2024 | globenewswire.comCANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMITMarch 19, 2024 | finance.yahoo.comvTv Therapeutics Inc.: vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate UpdateMarch 13, 2024 | finanznachrichten.devTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate UpdateMarch 13, 2024 | globenewswire.comvTv Therapeutics starts phase 3 trial for diabetes drugMarch 6, 2024 | investing.comThe Top 3 Healthcare Stocks to Buy on Weakness in 2024March 4, 2024 | investorplace.comvTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 DiabetesMarch 4, 2024 | globenewswire.comvTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare ConferenceMarch 1, 2024 | globenewswire.comvTv Therapeutics' stock doubles after raising $51 million from health care investors including JDRFFebruary 29, 2024 | bizjournals.comWhy Is Diabetes Focused vTv Therapeutics Stock Trading Higher Today?February 28, 2024 | msn.comvTv Therapeutics Inc. (VTVT)February 28, 2024 | finance.yahoo.comNasdaq Down 50 Points; US Crude Stocks Rise By 4.2M BarrelsFebruary 28, 2024 | markets.businessinsider.comVTv Therapeutics Shares Surge on $51 Million Private PlacementFebruary 28, 2024 | marketwatch.comTrading was temporarily halted for "VTVT" at 11:02 AM with a stated reason of "LULD pause." Trading set to resume at 11:02 AM. February 28, 2024 | marketbeat.comTrading was temporarily halted for "VTVT" at 11:02 AM with a stated reason of "LULD pause."February 28, 2024 | marketbeat.comTrading was temporarily halted for "VTVT" at 11:02 AM with a stated reason of "LULD pause."February 28, 2024 | marketbeat.comvTv Therapeutics Inc. Cl AFebruary 28, 2024 | wsj.comvTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D FundFebruary 28, 2024 | finance.yahoo.comvTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D FundFebruary 28, 2024 | globenewswire.comCANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCEFebruary 22, 2024 | prnewswire.comvTv Therapeutics Inc (VTVT)January 31, 2024 | uk.investing.comvTv Therapeutics Inc - Ordinary Shares - Class ANovember 27, 2023 | money.usnews.comvTv Therapeutics regains compliance with Nasdaq after 1-for-40 reverse stock splitNovember 21, 2023 | bizjournals.comTrading was temporarily halted for "VTVT" at 07:11 PM with a stated reason of "News pending."November 21, 2023 | marketbeat.comvTv Therapeutics loses $6.7M in Q3, could lose spot on NASDAQ indexNovember 15, 2023 | bizjournals.comvTv Therapeutics Stock (NASDAQ:VTVT) Earnings Dates and Earning CallsNovember 11, 2023 | benzinga.com Get vTv Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Musk’s new company could top a trillion? (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. VTVT Media Mentions By Week VTVT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VTVT News Sentiment▼0.930.77▲Average Medical News Sentiment VTVT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VTVT Articles This Week▼11▲VTVT Articles Average Week Get vTv Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LUMO News ACRS News IPHA News CRBU News GALT News SCLX News ADVM News CGEN News GBIO News TELO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VTVT) was last updated on 10/12/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredAI Expert Reveals New PickYour Financial Planner Won't Tell You About This Investment Strategy Silicon Valley insider Jeff Brown has ...Brownstone Research | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe Great Crypto Frenzy 2.0 is About to StartBitcoin’s Final Bull Run: Three Altcoins to Get Into NOW! “Crypto Whisperer” Ian King is calling it: due to...Banyan Hill Publishing | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredTiny Defense Firm Set for Huge Gains with New US ContractOne tiny defense firm just won a groundbreaking US military contract… That could hand early investors gains...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
